ALS LIMITED (ALQ)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ALQ - ALS LIMITED

Year End: March
GICS Industry Group : Commercial & Professional Services
Debt/EBITDA: 2.92
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

ALS Ltd provides laboratory and testing services across the mining, industrial and life sciences sector. It operates in over 65 countries. Formerly Campbell Brothers Ltd it first listed in 1952 and changed name to ALS in 2012.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$14.02

01 Nov
2024

-0.080

OPEN

$14.01

-0.57%

HIGH

$14.12

748,218

LOW

$13.98

TARGET
$15.425 10.0% upside
Franking for last dividend paid out: 20%
OTHER COMPANIES IN THE SAME SECTOR
3DA . AVD . BSA . CG1 . CLG . CVL . CWY . CXL . DOW . DUR . EGN . EVS . FLC . IPG . LBL . MAD . PPK . SDV . SHA . SND . SSM . VEE . VNT .
FNARENA'S MARKET CONSENSUS FORECASTS
ALQ: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx 2.7 64.3 xxx
DPS (cps) xxx 39.2 38.7 xxx
EPS Growth xxx - 95.4% 100.0% xxx
DPS Growth xxx - 1.3% - 1.3% xxx
PE Ratio xxx N/A 21.8 xxx
Dividend Yield xxx N/A 2.8% xxx
Div Pay Ratio(%) xxx 1468.2% 60.2% xxx

Dividend yield today if purchased 3 years ago: 2.90%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

2.80

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 12/06 - ex-div 19.6c (franking 20%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx2.7
DPS All xxxxxxxxxxxxxxx39.2
Sales/Revenue xxxxxxxxxxxxxxx2,461.6 M
Book Value Per Share xxxxxxxxxxxxxxx244.4
Net Operating Cash Flow xxxxxxxxxxxxxxx359.2 M
Net Profit Margin xxxxxxxxxxxxxxx0.52 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx1.01 %
Return on Invested Capital xxxxxxxxxxxxxxx0.48 %
Return on Assets xxxxxxxxxxxxxxx0.36 %
Return on Equity xxxxxxxxxxxxxxx1.01 %
Return on Total Capital xxxxxxxxxxxxxxx15.86 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx17.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx318 M
Long Term Debt xxxxxxxxxxxxxxx1,554 M
Total Debt xxxxxxxxxxxxxxx1,872 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx300 M
Price To Book Value xxxxxxxxxxxxxxx5.37

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx151.7 M
Capex % of Sales xxxxxxxxxxxxxxx6.16 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,624 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx371 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx46 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.9

No. Of Recommendations

4
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

20/09/2024

2

Accumulate

$14.90

6.28%

ALS Ltd announced a downgrade in earnings guidance with 1H25 EBIT expected to fall -5% on the previous corresponding period.

Ord Minnett highlights the company is experiencing volumes declines in Australia and Latin America due to political uncertainty. Higher interest costs of -$80m-plus compared to previous market expectations of -$67m are also impacting.

Weaker demand from China played a role with increased delays form clients raising capital before exploration projects can commence.

Life sciences with the environmental business performed well.

EPS forecasts fall by -8% in FY25 and -4% in FY26, the analyst notes, with an according fall in the target price to $14.90 from $15.10.

Accumulate rating unchanged.

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Goldman Sachs

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

23/09/2024

2

Overweight

$14.20

1.28%

Following ALS Ltd's 1H trading update, Jarden sees potential for consensus downgrades to both core profit and core EPS forecasts of around -5% and -7%, respectively.

The update highlighted deteriorating volumes in the Geochemistry business and higher net interest costs, explains the broker, both of which should drive an around -5% decline in "Core NPAT" relative to the 1H, according to management.

More positively, the Life Sciences business is proving resilient, which the analysts forecast will contribute circa 60%-70%  of incremental EBIT growth moving forward.

The target falls to $14.20 from $14.90. The Overweight. rating is kept given the recent fall in ALS Ltd's share price, explains Jarden.

FORECAST
Jarden forecasts a full year FY25 dividend of 36.80 cents and EPS of 64.20 cents.
Jarden forecasts a full year FY26 dividend of 42.60 cents and EPS of 71.90 cents.

ALQ STOCK CHART